Anna Granata1, Egidio Iorio2,
Maria Teresa Comito1, Alessandro Ricci2, Maria Elena
Pisanu2, Zaver M. Bhujwalla3,
1Fondazione IRCCS Ist. Nazionale Tumori, Milano, Mi, Italy; 2Cell Biology & Neurosciences, Istituto Superiore di Sanit, Roma, RM, Italy; 3John Hopkins University, Baltimore, MA, United States
Detection and characterization by magnetic resonance spectroscopy of altered phosphatidylcholine metabolism in epithelial ovarian cancer (EOC) could provide choline-based imaging approaches as powerful tools to improve diagnosis and identify new therapeutic targets.